Leishmaniasis, Visceral: all 68 studies
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With LeishmaniasisRecruitingNCT07783243
- LEISH-PED: Study on Leishmaniasis in ChildrenRecruitingNCT07504757
- Recurrent Visceral Leishmaniasis in HIV Co-InfectionRecruitingNCT07487350
- Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)RecruitingNCT06793111
- Clinical Prognostic Score to Predict Relapse in VLRecruitingNCT05602610
- Real World Study of Classic Infectious DiseaseRecruitingNCT04020536
- Diagnosis and Treatment of Leishmania InfectionsRecruitingNCT00344188
- Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort StudyCompletedNCT01360762Phase 3Results posted
- A First-in-human, Safety, Tolerability, and Pharmacokinetics Study of LXE408 in Healthy SubjectsCompletedNCT07809919Phase 1
- Ivermectin Repurposed for the Treatment of PKDLCompletedNCT07286604Early Phase 1
- Human Bioequivalence Study of Liposomal Amphotericin B for InjectionCompletedNCT06983665Not applicable
- Human Bioequivalence Study of Amphotericin B Liposome for InjectionCompletedNCT06977490Not applicable
- Repurposing Ivermectin for PKDL TreatmentCompletedNCT06251739Early Phase 1
- Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation StudyTerminatedNCT06118749
- LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept StudyCompletedNCT05957978Phase 2
- A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral LeishmaniasisCompletedNCT05593666Phase 2
- Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South SudanCompletedNCT05449717
- Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of CureCompletedNCT05426577
- Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in KenyaStatus unknownNCT05386875
- A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral LeishmaniasisActive, not recruitingNCT04342715
- A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)WithdrawnNCT04107961Phase 2
- LAMP Assay for the Diagnosis of Visceral LeishmaniasisCompletedNCT04003532
- Single Oral Dose Escalation Study of DNDI-0690 in Healthy SubjectsCompletedNCT03929016Phase 1
- Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern AfricaCompletedNCT03646981
- Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed ConditionCompletedNCT03636659Phase 1
- Short Course Regimens for Treatment of PKDL (Sudan)Status unknownNCT03399955Phase 2
- Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in BangladeshCompletedNCT03311607Phase 4
- Improved Case Detection and Vector Control for Visceral LeishmaniasisCompletedNCT03269006Not applicable
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaCompletedNCT03129646Phase 3
- Predicting Visceral Leishmaniasis in HIV Infected PatientsTerminatedNCT03013673
- Asymptomatic Leishmania Infection in HIV PatientsTerminatedNCT02839603
- Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern AfricaCompletedNCT02431143Phase 2
- Miltefosine for Children With PKDLCompletedNCT02193022Phase 3
- Visceral Leishmaniasis and Malnutrition in Amhara Regional State, EthiopiaCompletedNCT02148822
- Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult VolunteersCompletedNCT02071758Phase 1
- Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.CompletedNCT02011958Phase 3
- Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in SudanTerminatedNCT01980199Phase 2
- Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830Not applicable
- Replacement of Insecticides to Control Visceral Leishmaniasis (VL)CompletedNCT01644682Phase 3
- Single Dose Liposomal Amphotericin B for Visceral LeishmaniasisStatus unknownNCT01566552Phase 4
- An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in BangladeshCompletedNCT01328457Not applicable
- Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in BrazilTerminatedNCT01310738Phase 4
- A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in BangladeshCompletedNCT01240473Not applicable
- Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-AcetylcysteineStatus unknownNCT01138956Not applicable
- Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in BangladeshCompletedNCT01122771Phase 3
- A Community Trial for Visceral Leishmaniasis (VL)CompletedNCT01069198Not applicable
- Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern AfricaCompletedNCT01067443Phase 2
- Amphotericin B to Treat Visceral Leishmaniasis in Brazilian ChildrenCompletedNCT01032187Phase 4
- Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDLCompletedNCT00982774Phase 1
- To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala AzarCompletedNCT00876824Phase 3
- Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VLTerminatedNCT00832208Phase 2
- Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral LeishmaniasisCompletedNCT00696969Phase 3
- An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral LeishmaniasisCompletedNCT00629031Phase 3
- Single Infusion of Liposomal Amphotericin B in Indian Visceral LeishmaniasisCompletedNCT00628719Phase 3
- Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral LeishmaniasisCompletedNCT00604955Phase 4
- Combination Therapy in Indian Visceral LeishmaniasisCompletedNCT00523965Phase 3
- A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-AzarCompletedNCT00497601Phase 2
- Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in IndiaCompletedNCT00486382Phase 1
- A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.CompletedNCT00381394Phase 2
- Miltefosine for Brazilian Visceral LeishmaniasisTerminatedNCT00378495Phase 1/2
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azarCompletedNCT00371995Phase 2
- Combination Chemotherapy for the Treatment of Indian Kala-AzarCompletedNCT00370825Phase 2
- Immunogenetics of Visceral LeishmaniasisCompletedNCT00342823
- Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala AzarCompletedNCT00318721Not applicable
- Amphotericin B Treatment in Visceral LeishmaniasisCompletedNCT00310505Not applicable
- Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V LeishmaniasisCompletedNCT00255567Phase 3
- Safety and Efficacy Study of Paromomycin to Treat Visceral LeishmaniasisCompletedNCT00216346Phase 3
- Clinical Investigation of Infections Due to Leishmanial ParasitesCompletedNCT00001169